Roman Falls
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Roman Falls has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Sara Vogrin
The University of Melbourne Parkville Victoria Australia
4 shared publications - Bing Hui Wang
Biomarker Discovery Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia
2 shared publications - Christopher Neil
Cardiology Department, Western Health, Melbourne, Australia; Department of Medicine; and University of Melbourne, Melbourne, Australia
2 shared publications - Ingrid Hopper
Department of General Medicine Alfred Health Melbourne Victoria Australia
2 shared publications - Odgerel Tumur
Department of Medicine, Western Health, University of Melbourne, Melbourne, Australia
2 shared publications - Ralph Maddison
Institute for Physical Activity and Nutrition, Deakin University, Geelong, Australia
2 shared publications
Latest Publications
- Open Access
- 22 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 5928
Decreased Endogenous Nitric Oxide Production in Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction
Background: Heart failure with a preserved ejection fraction (HFpEF) accounts for approximately 50% of patients with heart failure. Endothelial dysfunction has been documented in HFpEF, and impaired nitric oxide (NO) production may be a contributing factor in patients decompensating from chronic to acute HFpEF. Plasma nitrite (NO2−), but not plasma nitrate (NO3−), is highly reflective of local nitric oxide production. However, plasma NO2− levels in relation to chronic and acute HFpEF patients have not been studied. Methods: Plasma NO2− and NO3− concentrations were quantified with gas-phase chemiluminescence. Plasma asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO production, and arterial stiffness were also quantified. Samples were collected from 19 participants with chronic HFpEF and 16 participants with acute HFpEF. Results: Plasma NO2− concentrations were lower in participants with acute HFpEF when compared to the chronic HFpEF group (p = 0.022). NO3−, ADMA and indices of arterial stiffness did not display any significant between-group differences. Conclusions: We present novel NO2− data, which has not been previously quantified in patients with acute HFpEF. Our results indicate that plasma concentrations of NO2− may be decreased in patients with acute HFpEF compared to patients with chronic HFpEF, suggesting a dysregulated NO pathway. Further studies are required to confirm these findings in this patient population.
- 22 August 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (17) , 5928
Open AccessDecreased Endogenous Nitric Oxide Production in Patients with Acute Decompensated Heart Failure with Preserved Ejection Fraction
Background: Heart failure with a preserved ejection fraction (HFpEF) accounts for approximately 50% of patients with heart failure. Endothelial dysfunction has been documented in HFpEF, and impaired nitric oxide (NO) production may be a contributing factor in patients decompensating from chronic to acute HFpEF. Plasma nitrite (NO2−), but not plasma nitrate (NO3−), is highly reflective of local nitric oxide production. However, plasma NO2− levels in relation to chronic and acute HFpEF patients have not been studied. Methods: Plasma NO2− and NO3− concentrations were quantified with gas-phase chemiluminescence. Plasma asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO production, and arterial stiffness were also quantified. Samples were collected from 19 participants with chronic HFpEF and 16 participants with acute HFpEF. Results: Plasma NO2− concentrations were lower in participants with acute HFpEF when compared to the chronic HFpEF group (p = 0.022). NO3−, ADMA and indices of arterial stiffness did not display any significant between-group differences. Conclusions: We present novel NO2− data, which has not been previously quantified in patients with acute HFpEF. Our results indicate that plasma concentrations of NO2− may be decreased in patients with acute HFpEF compared to patients with chronic HFpEF, suggesting a dysregulated NO pathway. Further studies are required to confirm these findings in this patient population.
- Open Access
- 1 March 2025
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (3) , 2278-2286
Decreased Endogenous Nitric Oxide Production in Acute Decompensated Heart Failure with a Reduced Ejection Fraction
Aims: Heart failure represents a substantial burden to both patients and healthcare systems worldwide. Nitric oxide (NO) dysregulation may play a key role in patients transitioning from chronic to acute heart failure with a reduced ejection fraction (HFrEF). Plasma nitrite (NO2−) is highly reflective of local nitric oxide production and has not been studied in acute HFrEF. This study aims to quantify measures of NO biology in patients with acute and chronic HFrEF. Methods and results: We utilized gas-phase chemiluminescence to determine plasma NO2− concentrations. Plasma asymmetric dimethylarginine (ADMA) and arterial stiffness were also measured. Plasma concentrations of NO2− and ADMA, in addition to arterial stiffness, were compared in participants with chronic HFrEF (n = 25) and acute HFrEF (n = 24). We observed lower concentrations of plasma NO2− in patients with acute HFrEF (P = 0.047). We also observed higher plasma concentrations of ADMA in participants with acute HFrEF (P < 0.001). Plasma NO2− and ADMA also displayed a significant negative correlation in the total cohort (Rs = −0.38, P = 0.017). There was no significant difference between groups regarding arterial stiffness measures. Conclusions: We present novel data with regard to plasma NO2− in both acute and chronic HFrEF. Our results indicate that patients with acute HFrEF have a relative deficiency of plasma NO2− whilst also displaying a relative increase in ADMA, a modulator of eNOS. Reduced NO bioavailability may therefore relate to impaired NO production in patients with acute decompensation, with implications for both treatment and prevention of episodes.
- 1 March 2025
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 12 (3) , 2278-2286
Open AccessDecreased Endogenous Nitric Oxide Production in Acute Decompensated Heart Failure with a Reduced Ejection Fraction
Aims: Heart failure represents a substantial burden to both patients and healthcare systems worldwide. Nitric oxide (NO) dysregulation may play a key role in patients transitioning from chronic to acute heart failure with a reduced ejection fraction (HFrEF). Plasma nitrite (NO2−) is highly reflective of local nitric oxide production and has not been studied in acute HFrEF. This study aims to quantify measures of NO biology in patients with acute and chronic HFrEF. Methods and results: We utilized gas-phase chemiluminescence to determine plasma NO2− concentrations. Plasma asymmetric dimethylarginine (ADMA) and arterial stiffness were also measured. Plasma concentrations of NO2− and ADMA, in addition to arterial stiffness, were compared in participants with chronic HFrEF (n = 25) and acute HFrEF (n = 24). We observed lower concentrations of plasma NO2− in patients with acute HFrEF (P = 0.047). We also observed higher plasma concentrations of ADMA in participants with acute HFrEF (P < 0.001). Plasma NO2− and ADMA also displayed a significant negative correlation in the total cohort (Rs = −0.38, P = 0.017). There was no significant difference between groups regarding arterial stiffness measures. Conclusions: We present novel data with regard to plasma NO2− in both acute and chronic HFrEF. Our results indicate that patients with acute HFrEF have a relative deficiency of plasma NO2− whilst also displaying a relative increase in ADMA, a modulator of eNOS. Reduced NO bioavailability may therefore relate to impaired NO production in patients with acute decompensation, with implications for both treatment and prevention of episodes.
- Open Access
- 22 December 2020
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 8 (12) , e18496
The Utility of Predicting Hospitalizations Among Patients With Heart Failure Using mHealth: Observational Study
Background: Heart failure decompensation is a major driver of hospitalizations and represents a significant burden to the health care system. Identifying those at greatest risk of admission can allow for targeted interventions to reduce this risk. Objective: This paper aims to compare the predictive value of objective and subjective heart failure respiratory symptoms on imminent heart failure decompensation and subsequent hospitalization within a 30-day period. Methods: A prospective observational pilot study was conducted. People living at home with heart failure were recruited from a single-center heart failure outpatient clinic. Objective (blood pressure, heart rate, weight, B-type natriuretic peptide) and subjective (4 heart failure respiratory symptoms scored for severity on a 5-point Likert scale) data were collected twice weekly for a 30-day period. Results: A total of 29 participants (median age 79 years; 18/29, 62% men) completed the study. During the study period, 10 of the 29 participants (34%) were hospitalized as a result of heart failure. For objective data, only heart rate exhibited a between-group difference. However, it was nonsignificant for variability (P=.71). Subjective symptom scores provided better prediction. Specifically, the highest precision of heart failure hospitalization was observed when patients with heart failure experienced severe dyspnea, orthopnea, and bendopnea on any given day (area under the curve of 0.77; sensitivity of 83%; specificity of 73%). Conclusions: The use of subjective respiratory symptom reporting on a 5-point Likert scale may facilitate a simple and low-cost method of predicting heart failure decompensation and imminent hospitalization. Serial collection of symptom data could be augmented using ecological momentary assessment of self-reported symptoms within a mobile health monitoring strategy for patients at high risk for heart failure decompensation.
- 22 December 2020
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 8 (12) , e18496
Open AccessThe Utility of Predicting Hospitalizations Among Patients With Heart Failure Using mHealth: Observational Study
Background: Heart failure decompensation is a major driver of hospitalizations and represents a significant burden to the health care system. Identifying those at greatest risk of admission can allow for targeted interventions to reduce this risk. Objective: This paper aims to compare the predictive value of objective and subjective heart failure respiratory symptoms on imminent heart failure decompensation and subsequent hospitalization within a 30-day period. Methods: A prospective observational pilot study was conducted. People living at home with heart failure were recruited from a single-center heart failure outpatient clinic. Objective (blood pressure, heart rate, weight, B-type natriuretic peptide) and subjective (4 heart failure respiratory symptoms scored for severity on a 5-point Likert scale) data were collected twice weekly for a 30-day period. Results: A total of 29 participants (median age 79 years; 18/29, 62% men) completed the study. During the study period, 10 of the 29 participants (34%) were hospitalized as a result of heart failure. For objective data, only heart rate exhibited a between-group difference. However, it was nonsignificant for variability (P=.71). Subjective symptom scores provided better prediction. Specifically, the highest precision of heart failure hospitalization was observed when patients with heart failure experienced severe dyspnea, orthopnea, and bendopnea on any given day (area under the curve of 0.77; sensitivity of 83%; specificity of 73%). Conclusions: The use of subjective respiratory symptom reporting on a 5-point Likert scale may facilitate a simple and low-cost method of predicting heart failure decompensation and imminent hospitalization. Serial collection of symptom data could be augmented using ecological momentary assessment of self-reported symptoms within a mobile health monitoring strategy for patients at high risk for heart failure decompensation.
- Open Access
- 11 May 2020
- Published by JMIR Publications Inc. in JMIR Preprints
The Utility of Predicting Hospitalizations Among Patients With Heart Failure Using mHealth: Observational Study (Preprint)
BACKGROUND Heart failure decompensation is a major driver of hospitalizations and represents a significant burden to the health care system. Identifying those at greatest risk of admission can allow for targeted interventions to reduce this risk. OBJECTIVE This paper aims to compare the predictive value of objective and subjective heart failure respiratory symptoms on imminent heart failure decompensation and subsequent hospitalization within a 30-day period. METHODS A prospective observational pilot study was conducted. People living at home with heart failure were recruited from a single-center heart failure outpatient clinic. Objective (blood pressure, heart rate, weight, B-type natriuretic peptide) and subjective (4 heart failure respiratory symptoms scored for severity on a 5-point Likert scale) data were collected twice weekly for a 30-day period. RESULTS A total of 29 participants (median age 79 years; 18/29, 62% men) completed the study. During the study period, 10 of the 29 participants (34%) were hospitalized as a result of heart failure. For objective data, only heart rate exhibited a between-group difference. However, it was nonsignificant for variability (P=.71). Subjective symptom scores provided better prediction. Specifically, the highest precision of heart failure hospitalization was observed when patients with heart failure experienced severe dyspnea, orthopnea, and bendopnea on any given day (area under the curve of 0.77; sensitivity of 83%; specificity of 73%). CONCLUSIONS The use of subjective respiratory symptom reporting on a 5-point Likert scale may facilitate a simple and low-cost method of predicting heart failure decompensation and imminent hospitalization. Serial collection of symptom data could be augmented using ecological momentary assessment of self-reported symptoms within a mobile health monitoring strategy for patients at high risk for heart failure decompensation.
- 11 May 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Utility of Predicting Hospitalizations Among Patients With Heart Failure Using mHealth: Observational Study (Preprint)
BACKGROUND Heart failure decompensation is a major driver of hospitalizations and represents a significant burden to the health care system. Identifying those at greatest risk of admission can allow for targeted interventions to reduce this risk. OBJECTIVE This paper aims to compare the predictive value of objective and subjective heart failure respiratory symptoms on imminent heart failure decompensation and subsequent hospitalization within a 30-day period. METHODS A prospective observational pilot study was conducted. People living at home with heart failure were recruited from a single-center heart failure outpatient clinic. Objective (blood pressure, heart rate, weight, B-type natriuretic peptide) and subjective (4 heart failure respiratory symptoms scored for severity on a 5-point Likert scale) data were collected twice weekly for a 30-day period. RESULTS A total of 29 participants (median age 79 years; 18/29, 62% men) completed the study. During the study period, 10 of the 29 participants (34%) were hospitalized as a result of heart failure. For objective data, only heart rate exhibited a between-group difference. However, it was nonsignificant for variability (P=.71). Subjective symptom scores provided better prediction. Specifically, the highest precision of heart failure hospitalization was observed when patients with heart failure experienced severe dyspnea, orthopnea, and bendopnea on any given day (area under the curve of 0.77; sensitivity of 83%; specificity of 73%). CONCLUSIONS The use of subjective respiratory symptom reporting on a 5-point Likert scale may facilitate a simple and low-cost method of predicting heart failure decompensation and imminent hospitalization. Serial collection of symptom data could be augmented using ecological momentary assessment of self-reported symptoms within a mobile health monitoring strategy for patients at high risk for heart failure decompensation.